These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11965543)

  • 1. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
    Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
    Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
    Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
    Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
    Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
    Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
    Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
    Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells.
    Jung BP; Jugloff DG; Zhang G; Logan R; Brown S; Eubanks JH
    J Neurobiol; 2003 Apr; 55(1):86-96. PubMed ID: 12605461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBD2 and MeCP2 regulate distinct transitions in the stage-specific differentiation of olfactory receptor neurons.
    Macdonald JL; Verster A; Berndt A; Roskams AJ
    Mol Cell Neurosci; 2010 May; 44(1):55-67. PubMed ID: 20188178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
    Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
    Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific windows for high mRNA expression of DNA methyltransferases 1 and 3A and methyl-CpG-binding domain proteins 2 and 4 in human fetal gonads.
    Galetzka D; Weis E; Tralau T; Seidmann L; Haaf T
    Mol Reprod Dev; 2007 Feb; 74(2):233-41. PubMed ID: 16998846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells.
    Koch C; Strätling WH
    Biochemistry; 2004 May; 43(17):5011-21. PubMed ID: 15109260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status.
    Müller HM; Fiegl H; Goebel G; Hubalek MM; Widschwendter A; Müller-Holzner E; Marth C; Widschwendter M
    Br J Cancer; 2003 Nov; 89(10):1934-9. PubMed ID: 14612906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.
    Evron E; Umbricht CB; Korz D; Raman V; Loeb DM; Niranjan B; Buluwela L; Weitzman SA; Marks J; Sukumar S
    Cancer Res; 2001 Mar; 61(6):2782-7. PubMed ID: 11289162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium.
    Plachot C; Lelièvre SA
    Exp Cell Res; 2004 Aug; 298(1):122-32. PubMed ID: 15242767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues.
    Asch HL; Eliacin E; Fanning TG; Connolly JL; Bratthauer G; Asch BB
    Oncol Res; 1996; 8(6):239-47. PubMed ID: 8895199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.